α 1proteinase inhibitor regulates CD4 + lymphocyte levels and is rate limiting in HIV-1 disease

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Bristow, Cynthia L ^a,b   Babayeva, Mariya A ^a,b   LaBrunda, Michelle ^c   Mullen, Michael P ^d   Winston, Ronald ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Institute for Human Genetics and Biochemistry   (Switzerland)

^c Holmes Regional Medical Center   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMINO ACID; CHEMOKINE RECEPTOR CXCR4; EPITOPE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LEUKOCYTE ELASTASE; STROMAL CELL DERIVED FACTOR 1; IMMUNOGLOBULIN G;

ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CD4 LYMPHOCYTE COUNT; CHIMPANZEE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOCOMPETENCE; MACACA MULATTA; MALE; NONHUMAN; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BLOOD; CD4+ T LYMPHOCYTE; CHEMISTRY; ENZYME ACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PAN TROGLODYTES; REGRESSION ANALYSIS; VIROLOGY;

ADULT; ALPHA 1-ANTITRYPSIN; ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; ENZYME ACTIVATION; EPITOPES; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MACACA MULATTA; MALE; PAN TROGLODYTES; PROTEIN BINDING; REGRESSION ANALYSIS;

EID: 84857166254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031383     Document Type: Article

References (58)

1. Yahata T, Yumino S, Seng Y, Miyatake H, Uno T, et al. (2006) Clonal analysis of thymus-repopulating cells presents direct evidence for self-renewal division of human hematopoietic stem cells. Blood 108: 2446-2454.
2. Lapidot T, Petit I, (2002) Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30: 973-981.
3. Tavor S, Petit I, Porozov S, Goichberg P, Avigdor A, et al. (2005) Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice. Blood 106: 2120-2127.
4. Cepinskas G, Sandig M, Kvietys PR, (1999) PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. J Cell Science 112: 1937-1945.
5. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC, (1999) Mutations in ELA2, encoding neutrophil elastase, define a 21-day clock in cyclic haematopoiesis. Nat Genet 23: 433436.
6. Horwitz M, Benson KF, Duan Z, Li FQ, Person RE, (2004) Hereditary neutropenia: dogs explain human neutrophil elastase mutations. Trends Mol Med 10: 163-170.
7. Benson KF, Li FQ, Person RE, Albani D, Duan Z, et al. (2003) Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet 35: 90-96.
8. Gullberg U, Lindmark A, Lindgren G, Persson AM, Nilsson E, et al. (1995) Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J Biol Chem 270: 12912-12918.
9. Garwicz D, Lennartsson A, Jacobsen SEW, Gullberg U, Lindmark A, (2005) Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica 90: 38-44.
10. Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, et al. (2003) Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 34: 308-312.
11. Banda MJ, Rice AG, Griffin GL, Senior RM, (1988) α1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. J Biol Chem 263: 4481-4484.
12. Kuiperij HB, van Pel M, de Rooij KE, Hoeben RC, Fibbe WE, (2009) SerpinA1 (α1-AT) is synthesized in the osteoblastic stem cell niche. Exp Hematol 37: 641-647.
13. Bristow CL, Cortes J, Mukhtarzad R, Trucy M, Franklin A, et al. (2010) α1Antitrypsin therapy increases CD4+ lymphocytes to normal values in HIV-1 patients. In: Alfano M, editors. Soluble factors mediating innate immune responses to HIV infection Bentham Science Publishers, Open Access Plus Available: http://www.benthamdirect.org/pages/openAccess.php. Accessed 2012 Jan 10.
14. Owen FL, Peterman GM, (1984) Neoplastic model for the differentation of a subpopulation of lymphocytes bearing. Immunological Reviews 82: 29-46.
15. Bristow CL, Flood PM, (1993) T cell antigen receptor immune complexes demonstrating biologic and proteolytic activity. Int Immunol 5: 79-88.
16. Cai TQ, Wright SD, (1996) Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18,Mac-1,αMβ2) and modulates polymorphonuclear leukocyte adhesion. J Exp Med 184: 1213-1223.
17. Strickland DK, Gonias SL, Argraves WS, (2002) Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13: 66-74.
18. Cao C, Lawrence DA, Li Y, Von Amin CA, Herz J, et al. (2006) Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J 25: 1860-1870.
19. Bristow CL, Mercatante DR, Kole R, (2003) HIV-1 preferentially binds receptors co-patched with cell surface elastase. Blood 102: 4479-4486.
20. Bristow CL, Wolkowicz R, Trucy M, Franklin A, Di Meo F, et al. (2008) NF-κB Signaling, Elastase Localization, and Phagocytosis Differ in HIV-1 Permissive and Nonpermissive U937 Clones. J Immunol 180: 492-499.
21. Bristow CL, Fiscus SA, Flood PM, Arnold RR, (1995) Inhibition of HIV-1 by modification of a host membrane protease. Int Immunol 7: 239-249.
22. Shapiro L, Pott GB, Ralston AH, (2001) Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J 15: 115-122.
23. Munch J, Standker L, Adermann K, Schulz A, Schindler M, et al. (2007) Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide. Cell 129: 263-275.
24. Cordelier P, Strayer DS, (2003) Mechanisms of a1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis. Biochim Biophys Acta 1638: 197-207.
25. Martodam RR, Liener IE, (1981) The interaction of alpha 1-antitrypsin with trypsin, chymotrypsin and human leukocyte elastase as revealed by end group analysis. Biochim Biophys Acta 667: 328-340.
26. Misumi Y, Oda K, Fujiwara T, Takami N, Tashiro K, et al. (1991) Functional Expression of Furin Demonstrating Its Intracellular Localization and Endoprotease Activity for Processing of Proalbumin and Complement Pro-C3*. J Biol Chem 266: 16954-16959.
27. Winkler IG, Hendy J, Coughlin P, Horvath A, Levesque JP, (2005) Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. The Journal of Experimental Medicine 201: 1077-1088.
28. Molmenti EP, Perlmutter DH, Rubin DC, (1993) Cell-specific expression of α1-antitrypsin in human intestinal epithelium. J Clin Invest 92: 2022-2034.
29. Ribeiro RM, Mohri H, Ho DD, Perelson AS, (2002) In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted? Proc Natl Acad Sci USA 99: 15572-15577.
30. Hellerstein MK, Hoh RA, Hanley MB, Cesar D, Lee D, et al. (2003) Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 112: 956-966.
31. Bristow CL, Patel H, Arnold RR, (2001) Self antigen prognostic for human immunodeficiency virus disease progression. Clin Diagn Lab Immunol 8: 937-942.
32. Moore JP, Sattentau QE, Wyatt R, Sodroski J, (1994) Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol 68: 469-484.
33. Rutjens EB-J, Verschoor E, Bogers W, Koopman G, Heeney J, (2003) Lentivirus infections and mechanisms of disease resistance in chimpanzees. Front Biosci 8: d1134-d1145.
34. Girard M, Mahoney J, Wei A, van der Ryst E, Muchmore E, et al. (1998) Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 14: 1357-1367.
35. Arthur LO, Bess JW Jr, Sowder RC II, Benveniste RES, Mann DL, et al. (1992) Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science 258: 1935-1938.
36. Rossio JL, Esser MT, Suryanarayana K, Schneider DK, Bess JW Jr, et al. (1998) Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 72: 7992-8001.
37. Joslin G, Fallon RJ, Bullock J, Adams SP, Perlmutter DH, (1991) The SEC receptor recognizes a pentapeptide neodomain of alpha-1- antitrypsin-protease. J Biol Chem 266: 11282-11288.
38. Janciauskiene S, Moraga F, Lindgren S, (2001) C-terminal fragment of [alpha]1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor. Atherosclerosis 158: 41-51.
39. Virella G, Wohltmann H, Sagel J, Lopes-Virella MFL, Kilpatrick M, et al. (1981) Soluble immune complexes in patients with Diabetes Mellitus: Detection and pathological significance. Diabetologia 21: 184-191.
40. Moore JP, Cao Y, Ho DD, Koup RA, (1994) Development of the anti-gp120 antibody responses during seroconversion to human immunodeficiency virus type 1. J Virol 68: 5142-5155.
41. Ratner L, Haseltine W, Patarca R, Livak KJ, Starcich B, et al. (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277-284.
42. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, et al. (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512.
43. Jeppsson JO, Lilja H, Johansson M, (1985) Isolation and characterization of two minor fractions of [alpha]1,-antitrypsin by high-performance liquid chromatographic chromatofocusing. J Chromatogr A 327: 173-177.
44. Strickland DK, Kounnas MZ, (1997) Mechanisms of Cellular Uptake of Thrombin-Antithrombin II Complexes Role of the Low-Density Lipoprotein Receptor-Related Protein as a Serpin-Enzyme Complex Receptor. Trends in Cardiovascular Medicine 7: 9-16.
45. Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, et al. (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265: 10373-10382.
46. Wei X, Decker JM, Wang S, Hui H, Kappes JC, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422: 307-312.
47. Cygler M, Rose DR, Bundle DR, (1991) Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253: 442-445.
48. Freissmuth D, Dierich MP, Stoiber H, (2003) Role of complement in the pathogeneis of SIV infection. Front Biosci 8: S733-S739.
49. Marlink R, Kanki P, Thior I, Travers K, Eisen G, et al. (1994) Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265: 1587-1590.
50. Rubinstein DB, Farrington GK, O'Donnell C, Hartman KR, Wright DG, (1999) Autoantibodies to Leukocyte [alpha]M[beta]2 Integrin Glycoproteins in HIV Infection. Clinical Immunology 90: 352-359.
51. Haynes BF, Fleming J, St. Clair EW, Katinger H, Stiegler G, et al. (2005) Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies. Science 308: 1906-1908.
52. Koito A, Hattori T, Murakami T, Matsushita S, Maeda Y, et al. (1989) A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inte-α-trypsin inhibitor. Int Immunol 1: 613-618.
53. Golding H, Robey FA, Gates FT III, Linder W, Beining PR, et al. (1988) Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 167: 914-923.
54. Amara A, Chaugier C, Ragnaud J-M, Geffard M, (1994) Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1 infected patients. Clin Exp Immunol 96: 379-383.
55. Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies ME, et al. (1997) Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. PNAS 94: 9378-9383.
56. Rodman TC, Sullivan JJ, Bai X, Winston R, (1999) The human uniqueness of HIV: innate immunity and the viral Tat protein. Hum Immunol 50: 631-639.
57. Girard M, van der Ryst E, Barre-Sinoussi F, Nara P, Tartaglia J, et al. (1997) Challenge of Chimpanzees Immunized with a Recombinant Canarypox-HIV-1 Virus. Virology 232: 98-104.
58. Bristow CL, di Meo F, Arnold RR, (1998) Specific activity of α1proteinase inhibitor and α2macroglobulin in human serum: Application to insulin-dependent diabetes mellitus. Clin Immunol Immunopathol 89: 247-259.